NCT01535638View on ClinicalTrials.gov

Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2012

Conditions
Healthy
Interventions
DRUG

BI 207127

Medium dose film-coated tablet

DRUG

BI 207127

Medium dose film-coated tablet

DRUG

BI 207127

Medium dose film-coated tablet

Trial Locations (1)

Unknown

1241.26.1 Boehringer Ingelheim Investigational Site, Ingelheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01535638 - Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter